Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00304369 · ClinicalTrials.gov registry record
Response of Clostridium Difficile Infection to Metronidazole Therapy
A clinical trial, sponsored by Michael E. DeBakey VA Medical Center.
- Completed
- Registry status
- 290
- Enrollment target
NCT00304369: Completed study, sponsored by Michael E. DeBakey VA Medical Center.
NCT00304369 is a clinical trial that has completed, run by Michael E. DeBakey VA Medical Center. The registered enrollment target is 290 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00304369 has completed, sponsored by Michael E. DeBakey VA Medical Center.
- COMPLETED
- Registry status
- 290 participants
- Enrollment target
Study Summary
In this record review study, our objective is to determine the rates of cure, failure and relapse following treatment of C. difficile colitis with metronidazole.
Interventions
- DRUG Metronidazole
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 290 participants |
| Start Date | 2005-06 |
| Est. Completion | 2007-06 |
What the finished NCT00304369 record still lists
NCT00304369 is an observational study that tracks outcomes without assigning an intervention. The registered 290 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Metronidazole is the first listed.
NCT00304369 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00304369 about?
NCT00304369 is a clinical study titled "Response of Clostridium Difficile Infection to Metronidazole Therapy". In this record review study, our objective is to determine the rates of cure, failure and relapse following treatment of C. difficile colitis with metronidazole.
What is the current status of trial NCT00304369?
This trial is currently completed. The enrollment target is 290 participants. The study started on 2005-06. Estimated completion is 2007-06.
What interventions are being tested in trial NCT00304369?
The interventions under investigation include: Metronidazole (DRUG).
Who is sponsoring clinical trial NCT00304369?
This trial is sponsored by Michael E. DeBakey VA Medical Center, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00775476 · 290 participants · Phase 2
Treatment of Systemic Lupus Erythematosus (SLE) With N-acetylcysteine
- NCT01874197 · 290 participants · NA
Branched Thoracic Endovascular Grafts for the Treatment of Thoraco-abdominal Aortic
- NCT04331353 · 290 participants · NA
The Allergen Reduction and Child Health Study (ARCHS)
- NCT04649008 · 290 participants · Early Phase 1
Localizing Epileptic Networks Using MRI and iEEG
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia